BGI customers to receive QIAGEN software
QIAGEN and BGI have announced the expansion of their relationship, with QIAGEN’s Ingenuity Variant Analysis software to be provided to customers of BGI’s sequencing services.
Under the reseller agreement, BGI customers will receive sequencing data generated from their samples through Ingenuity Variant Analysis’s secure, cloud-based environment and gain access to its comprehensive gene variant data and genomic interpretation applications. The software will be provided by BGI to customers in China, Hong Kong and Taiwan, with plans to expand to other regions throughout the year.
“We welcome this opportunity to expand our relationship with QIAGEN for the benefit of BGI collaborators around the world,” said BGI Chief Scientist Yingrui Li. “Coupling BGI’s world-class sequencing with the deep bioinformatics of Ingenuity Variant Analysis will give researchers an enhanced, integrated way to seamlessly move quickly from raw data to valuable insights.”
The software quickly filters genetic variants in a cloud-based environment to identify variants most likely to cause disease. The product draws on the Ingenuity Knowledge Base, a repository of expertly curated biological interactions and functional annotations created from millions of individually modelled relationships between proteins, genes, complexes, cells, tissues, drugs and diseases.
“Integrating Ingenuity Variant Analysis into BGI’s highly reliable sequencing services will enable clients to accelerate workflows,” added Laura Furmanski, the head of QIAGEN’s Bioinformatics Business Area. “They’ll be able to transform large quantities of genomic data into valuable molecular insights for research or clinical applications.”
Evident names 5th Annual Image of the Year Award winners
View the six winning entries in Evident's 5th Annual Image of the Year Award — a...
Fellowships and scholarships support women in science
The L'Oréal-UNESCO For Women in Science initiative has honoured five trailblazing...
2024 GSK Award recognises neurodegeneration researcher
Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in...